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Potential Drug Interaction with Coumadin
(Warfarin) and Prozac (Fluoxetine): A Brief
Report and Review of the Literature
Robert Jay Claire, M.D.
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Abstract

We were askedto see a woman with recurrent depression and a history if deep vein thrombosis.
(Consultation and L iaison Service). She had been started initially on Prorac (fl uoxetine) and was
secondarily started on Coumadin (uiaifarin). The patient presented with severe bruising if both
lower extremities. We were asked to investigate the case to determine if a drug interaction with
Prozac had produced the problem. A review if the world's literaturefai led to produce a report if a
drug interaction between Prozac and Coumadin producing a bleeding disorder. Scrutiny if this case
could not produce evidence that this occurred. A retrospective analysis if 4 additional cases was
performed. None if thesepatients required adjustment if their Coumadin while on Prozac.
It would be reasonable to assum e that as th e m ean age of th e U nited States
population rises , th e inciden ce of como rbid m edi cal a nd psychi a tric d isease is
incr easing. Patient s a re oft en pr escribed m edi cations whi ch m ay int e ract with
psychotropic drugs . Second-generation ant idepressants a re ge ne ra lly co ns id e red safe
dr ugs in th e m edi call y ill popu lation beca use of t heir minim al a n t icho line rg ic
properti es and fewer adve rse sid e effec ts. Fo r th e ph ysician , a kn owled ge of drug
int eractions with th e most co m mo nly prescribed psychotropic m edi catio ns is no t only
helpful , but should be th e standa rd of ca re.
Rece n tly, we were asked to see a woman with recurrent d epression a nd a history
of deep ve in thrombosis . Sh e had been initially s tar te d o n Pro zac (fluo xe t ine ) an d
was se condarily started on Co umad in (warfarin) . The pat ient pr esent ed with seve re
bru ising of bot h lowe r ex t re mi t ies a nd a seco ndary cellu litis . An added co m plica ting
fact was that she had a Di pthe ria , Pertussis, T et anus vaccination 3 week s prior to
ad m issio n. Bot h ce llulitis and th e D .P.T. va ccin at ion pot entiall y int e rfe re with
coag ula t io n. On admission her Pro t h ro m bin Tim e (PT) was 50 a nd Part ial Th romb oplastin Tim e (PTT) was 100, a sce nario more co ns iste nt with a coagulopa thy rath er
than Coumadin toxicity.
Whe n as ked to consu lt on this case , we had to investigat e th e possibil ity of
P ro zac int e ract ing wit h Coumadin. The Ph ysicia ns Desk Refere nce ca u tions agains t
coa d m iniste ring th e two dr ugs . (I)
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Co u madin, a co m mo nly pr escribed a nt icoagula n t, is bound to th e sam e plasma
pr ot ei n which binds Prozac. It is possibl e th at Pr ozac m ay di splace Coum adin from its
binding prot e in a nd result in a n incr ease in a fr ee fract ion of Coumadin , ca using a n
incr ease in Protim e ( 1,3,). A se a rc h of th e m edi cal lit era ture fai ls to de monst ra te a ny
cases of Pro zac int eracting with C oumadin (2). In our case , a d efini te ca use a nd effec t
linka ge co uld not be es tablishe d.
It was th en elec te d to perform a ret rosp ecti ve char t revi ew of pati ent s who were
coa d mi niste re d Pro zac a nd Coum ad in . T o dat e, we have rev iewed an addition al 4
ca ses .
Patient A is a 75 year old whit e mal e with a hist ory of chro nic ob structiv e
pulmon a ry disease, co ro na ry a r tery di sease, multiple myoca rdi a l infarct s, a t ria l
fibrilla t ion, a nd recurrent t ransient isch e mic a t tacks. Th e patie n t was found to ha ve
m aj or d epression a nd mild dem entia. H e had been on lon g term Coumadin th er ap y
pri or to th e initiation of Prozac. At this juncture, Pr ozac a nd Co umadi n have j ointly
been administered for I yea r. Th e patient maint a in ed his PT ra tio between 1.3 a nd
1.5 of PT co n t ro l range wit ho u t need to adj us t th e dosa ge.
Patient B, a 67 year old m al e, has a history of mu ltiple ce re bra l vasc ular
acc ide n ts. H e pres ent ed to Ment al H ygi en e C linic wit h major depressi on . T o dat e, he
has been m aint ained on Pr oza c a nd Co u mad in for eig ht week s. Hi s PT has rema ined
within sa t isfac tory cuntrollimits without having to be adju st ed .
Pati ent C, a 73 year old m al e, is sta t us post coro na ry a rt e ry bypass graft , a nd II
periph eral vascula r by-pass g ra fts . H e has a hist ory of deep vein t hrombophl ebit is a nd
has been m a intain ed on C ou mad in th erap y for 12 years . H e was sta r t ed on Prozac for
depression 2 years ago. T o dat e he ha s required no special ad justm ent to st ay within
con t rol range.
Pati ent D is a 67 year old mal e with a histo ry of dee p vei n t hrombophleb iti s,
pulmon a ry e m bo li a nd sq uamo us ce ll ca rcinom a of t he tong ue. H e has undergon e
radi cal neck di ssecti on a nd ex te rnal beam radi ation t herapy. The patient has been on
C oum adin for 12 years. Hi s psychi atric hist or y is remarkabl e for schizophreni a a nd
int ermitt ent depression . H e wa s placed on Pr ozac 3 months ago, wh en he experie nce d o rt hos tat ic blood pressure cha nges fr om his t ricyclic a ntidepressant s. In th e
int ervening period , he has required no specia l dosa ge adjustm ent to stay within
param et ers.
Our purpose in writing thi s report is to inform o t he r cli nicians t ha t although in
theory Coumadin a nd Prozac may int eract a nd a lte r Prothrombin Tim e, th e po tential a t this tim e a ppe a rs small. Both Cou mad in an d Pr ozac ca n eas ily be displaced by
o t her highl y pr ot ein bound drugs. Proza c does not a ppea r to alter the outcom e of
a n ticoag ula n t th erapy sig nifica n t ly in th e pa t ie n ts p resen te d.
No cases of C oumadin int eracting with Pro zac have a ppeared in th e world 's
lit erature (2) . Our inv estigation involves 5 patient s a nd ca nno t be conside red
definitive. It would be prudent to st udy a larger population before th e safet y of it s
com bina tio n with C oumadin ca n be det e rmined .
Eli Lilly a nd Compan y, th e manufacturers of Pr ozac, re por t that as ofJune 30,
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1990, a pp roximate ly 2,382 ,000 pa ti ents have bee n on Prozac. T here have be en only 24
rep ort ed cases of incr ease in bleeding tim e, coagulation d iso rd er , or coa gu la t ion tim e
increase. W e do not kn ow wh e th e r a ny of th ese pa t ien ts were concurrently on Pr ozac
and Coumadin . It is our hop e th a t t his art icle challenges ot he r investigat or s.
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